≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Oral lichen ruber planus, hypothyreosis or thyroxin

Endpoint Browser

K11_ORAL_LICHEN_HYPOT_THYRO

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

  • HYPOT_THYRO_INCL
66417

3. Check pre-conditions, main-only, mode, registry filters

None

0 out of 7 registries used, show all original rules.

0

4. Check minimum number of events

None

0

5. Include endpoints

533

6. Filter based on genotype QC (FinnGen only)

533

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF8

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 533 494 39
Unadjusted period prevalence (%) 0.16 0.17 0.02
Median age at first event (years) 65.49 65.40 66.70

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
449
Matched controls
4490
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K13.74
ICD-10 Finland
Lichen rubs planus in the mouth
+∞
323.0
449
24
H03AA01
ATC
levothyroxine sodium; systemic
863.8
268.2
447
938
EKA10
NOMESCO Finland
Biopsy of cheek
50.6
130.6
157
47
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
12.3
113.4
247
404
SAA03
NOMESCO Finland
Extended examination of mouth
9.2
96.0
351
1259
L43.8
ICD-10 Finland
Other lichen planus
36.0
86.4
112
41
L43.9
ICD-10 Finland
Lichen planus, unspecified
36.5
83.0
107
38
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
22.5
78.5
117
69
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
26.7
67.1
94
44
WZB00
NOMESCO Finland
Telephone receipt or other advice
4.8
51.4
246
907
104
Kela drug reimbursment
Thyroid insufficiency
7.2
48.0
130
241
SAA02
NOMESCO Finland
Basic examination of mouth
5.5
47.6
382
2283
SAA01
NOMESCO Finland
Simple examination of mouth
6.8
46.7
407
2640
SBA00
NOMESCO Finland
Microbiological examinations
17.1
46.3
75
52
D07AC01
ATC
betamethasone; topical
4.2
45.5
267
1152
D07AD01
ATC
clobetasol; topical
4.7
41.4
175
539
K13.78
ICD-10 Finland
Other change in the oral mucosa
15.7
37.9
63
46
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.7
37.3
246
1103
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
14.2
36.3
63
51
L43
ICD-10 Finland
Lichen planus
18.6
36.1
56
34
SXA10
NOMESCO Finland
Epithel biopsy of mouth
32.6
35.9
47
16
E03
ICD-10 Finland
Other hypothyroidism
6.9
33.2
89
156
WX110
NOMESCO Finland
Local anesthesy
3.9
30.8
375
2534
L43.0
ICD-10 Finland
Hypertrophic lichen planus
63.0
30.6
35
6
SFA10
NOMESCO Finland
Fillning on one surface of tooth
3.2
29.1
312
1869
K13.29
ICD-10 Finland
Indefinite leukoplakia
19.4
29.0
44
25
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
3.1
28.3
245
1256
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
3.0
27.5
286
1645
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
3.1
26.7
322
2023
R01AD11
ATC
triamcinolone; nasal
4.7
25.9
97
249
K02.1
ICD-10 Finland
Caries of dentine
2.9
24.7
307
1914
A07AA02
ATC
nystatin; oral
5.4
24.6
79
171
SDA02
NOMESCO Finland
Parodonthologic therapy
2.9
24.4
217
1097
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
2.8
24.3
270
1566
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.8
24.1
246
1351
Z01.2
ICD-10 Finland
Dental examination
2.8
23.8
253
1422
E03.89
ICD-10 Finland
Other specified hypothyroidism
7.1
23.8
60
95
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
6.7
23.4
62
105
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
6.8
22.7
59
97
T86
ICPC
Hypothyroidism/myxoedema
6.6
22.6
60
102
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
2.7
21.7
279
1714
ECA20
NOMESCO Finland
Biopsy of gingiva
16.6
21.4
34
22
EB1AA
NOMESCO Finland
Tooth X-ray examination
2.7
21.3
308
2013
D20
ICPC
Mouth/tongue/lip symptom/complaint
6.5
20.3
54
92
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
2.9
19.9
156
705
KMAK
NOMESCO Finland
NA
2.5
18.7
283
1827
VALMI
NOMESCO Finland
NA
2.7
18.0
153
718
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
2.4
17.1
231
1380
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
2.5
16.2
163
830
-1
NOMESCO Finland
NA
2.4
15.4
183
1012
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
2.5
15.3
157
806
K03.64
ICD-10 Finland
Dental calculus supragingival
2.4
15.0
167
893
D82
ICPC
Teeth/gum disease
2.2
14.0
192
1125
B37.08
ICD-10 Finland
Other candidal stomatitis
18.3
14.0
21
12
WZA90
NOMESCO Finland
Other doctors statement
2.4
13.9
144
734
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.6
13.8
114
514
A01AB09
ATC
miconazole; local oral
3.4
13.5
69
228
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
2.4
13.2
144
749
SAA04
NOMESCO Finland
Special inverstigation of mouth
4.2
13.0
51
134
E0000UV
ATC
NA
2.1
13.0
224
1436
WX290
NOMESCO Finland
Other blockade of nerve
2.1
13.0
212
1326
K04.5
ICD-10 Finland
Chronic apical periodontitis
2.3
12.9
146
775
S02.51
ICD-10 Finland
Fracture of tooth, open
3.1
12.6
74
266
D07AB02
ATC
hydrocortisone butyrate; topical
2.2
12.6
161
903
K05.1
ICD-10 Finland
Chronic gingivitis
3.8
12.2
52
148
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
3.8
11.9
51
146
B37.03
ICD-10 Finland
Chronic atrophic candida infection in the mouth
30.9
11.7
15
5
SDA01
NOMESCO Finland
Simple parodonthologic therapy
2.2
11.6
150
837
R01AD09
ATC
mometasone; nasal
2.0
11.4
248
1713
J02AC01
ATC
fluconazole; systemic
2.0
11.3
250
1733
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
2.2
11.2
149
839
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
14.4
11.1
18
13
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
10.9
160
940
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
5.9
10.9
30
54
K12.10
ICD-10 Finland
Stomatitis NOS
28.8
10.8
14
5
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
2.8
10.6
72
288
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.9
10.4
238
1654
L43.3
ICD-10 Finland
Subacute (active) lichen planus
33.4
10.4
13
*
A02BC05
ATC
esomeprazole; systemic
1.9
10.4
227
1551
K05.30
ICD-10 Finland
Periodontitis complex
2.7
10.3
76
317
A06AC01
ATC
ispaghula (psylla seeds); oral
2.1
10.2
152
895
SFA00
NOMESCO Finland
Small filling
2.5
9.9
82
366
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
2.0
9.7
324
2550
TEW99
NOMESCO Finland
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
4.2
9.7
36
91
K02.0
ICD-10 Finland
Caries limited to enamel
2.6
9.5
72
305
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
2.9
9.4
58
218
E03.80
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
6.3
9.3
24
40
R06AE07
ATC
cetirizine; oral
1.9
9.3
232
1640
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
2.6
9.2
73
317
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
4.9
9.2
29
62
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
37.5
9.1
11
*
A02BC02
ATC
pantoprazole; systemic
1.9
9.0
321
2548
L90.0
ICD-10 Finland
Lichen sclerosus et atrophicus
3.8
9.0
37
103
EJ2S1
NOMESCO Finland
Photography of oral mucosa
19.1
9.0
13
7
D07AB08
ATC
desonide; topical
2.7
8.7
62
255
C02.11
ICD-10 Finland
Malignant neoplasm of border of tongue
28.1
8.5
11
*
K13.20
ICD-10 Finland
Idiopathic leukoplakia
13.1
8.4
14
11
SBB10
NOMESCO Finland
Teeth copy
3.4
8.3
39
121
BAA40
NOMESCO Finland
Unilateral lobectomy of thyroid gland
4.7
8.3
27
60
D07AC13
ATC
mometasone; topical
1.9
8.3
154
969
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
2.0
8.1
123
717
EJB10
NOMESCO Finland
Excision of lesion of apex or body of tongue
17.6
8.1
12
7
UJF32
NOMESCO Finland
Coloscopy
1.9
8.1
138
842
M79.1
ICD-10 Finland
Myalgia
2.3
8.0
74
349
SCA03
NOMESCO Finland
Preventive oral health care, extensive
3.9
8.0
32
87
XQ802
NOMESCO Finland
Epicutan test
3.6
8.0
35
103
N03AX16
ATC
pregabalin; oral
1.9
8.0
136
829
SXA20
NOMESCO Finland
Local application of medicine to mouth
3.2
7.9
40
132
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
2.6
7.8
59
251
SFA40
NOMESCO Finland
Replacement of krone of tooth
2.0
7.7
115
665
R06AX27
ATC
desloratadine; oral
1.9
7.7
141
878
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.4
7.6
64
288
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
4.1
7.6
28
71
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
3.0
7.6
44
159
K05.31
ICD-10 Finland
Periodontitis pronounced
2.6
7.5
57
241
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
2.7
7.4
50
197
L28.0
ICD-10 Finland
Lichen simplex chronicus
7.0
7.4
17
25
N02AX02
ATC
tramadol; systemic, rectal
1.7
7.3
202
1435
B37.01
ICD-10 Finland
Acute athrophy candidal stomatitis
20.4
7.2
10
5
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.3
7.1
66
312
L01
ICPC
Neck symptom/complaint
2.1
7.0
79
406
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
2.6
6.9
51
213
N06AA09
ATC
amitriptyline; systemic
2.2
6.9
71
353
A01AC01
ATC
triamcinolone; local oral
5.2
6.9
20
40
-50
ICPC
Medication/prescr/renewal
3.5
6.9
30
89
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.2
6.9
70
343
M01AH05
ATC
etoricoxib; oral
1.7
6.9
283
2244
E000006
ATC
NA
2.5
6.9
53
227
N02BE01
ATC
paracetamol; systemic, rectal
2.2
6.9
403
3594
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.4
6.8
59
269
EBA00
NOMESCO Finland
Extraction of tooth
1.8
6.8
151
998
A02BC03
ATC
lansoprazole; oral
1.8
6.7
156
1044
K60.1
ICD-10 Finland
Chronic anal fissure
5.1
6.7
20
41
PAD
NOMESCO Finland
NA
22.9
6.7
9
*
R03AC02
ATC
salbutamol; inhalant
1.7
6.7
256
1981
K03.1
ICD-10 Finland
Abrasion of teeth
4.5
6.6
22
51
SXC03
NOMESCO Finland
Other oral or dental procedure
10.2
6.6
12
12
E000001
ATC
NA
1.9
6.6
108
644
R01AD12
ATC
fluticasone furoate; nasal
1.7
6.5
150
1000
K03.80
ICD-10 Finland
Irradiated enamel
3.3
6.5
31
99
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
2.2
6.4
66
327
P06
ICPC
Sleep disturbance
2.4
6.4
54
243
K13
ICD-10 Finland
Other diseases of lip and oral mucosa
70.8
6.4
7
*
-34
ICPC
Blood test
4.5
6.4
21
48
SXC05
NOMESCO Finland
Other oral or dental procedure
3.0
6.4
36
126
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.8
6.4
119
739
TEA00
NOMESCO Finland
Biopsy of lip
8.3
6.4
13
16
B37.0
ICD-10 Finland
Candidal stomatitis
8.3
6.4
13
16
G44.2
ICD-10 Finland
Tension-type headache
2.1
6.4
75
393
M03BX02
ATC
tizanidine; oral
1.7
6.3
298
2422
L15
ICPC
Knee symptom/complaint
1.8
6.3
116
719
P01BA02
ATC
hydroxychloroquine; oral
2.3
6.3
58
273
A01AB04
ATC
amphotericin B; local oral
3.0
6.3
34
119
L08
ICPC
Shoulder symptom/complaint
1.9
6.2
104
622
B81
ICPC
Anaemia vit B12/folate deficiency
3.5
6.2
27
80
EMAK
NOMESCO Finland
NA
3.6
6.2
26
75
M25.5
ICD-10 Finland
Pain in joint
1.7
6.2
142
943
M01AE02
ATC
naproxen; oral, rectal
1.6
6.2
266
2107
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
6.1
175
1237
EB1CA
NOMESCO Finland
Tooth X-ray additional picture
2.3
6.1
54
248
A02BC04
ATC
rabeprazole; oral
2.3
6.1
54
250
K29.4
ICD-10 Finland
Chronic atrophic gastritis
5.3
6.1
17
33
R01AD01
ATC
beclometasone; nasal
2.0
6.0
84
470
R06AX22
ATC
ebastine; oral
1.9
6.0
96
565

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3026389) Candida sp identified in Specimen by Organism specific culture
87
64
16.05
96.01
2.2
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
347
2024
3.05
33.09
2.6
2.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
150
580
3.21
29.57
1.8
1.3
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
84
316
2.97
16.70
2.9
3.3
pmol/l
4.0
4.5
5.62
76
275
(3013707) Erythrocyte sedimentation rate by Westergren method
448
3597
2.54
14.33
5.4
4.4
mm/h
13.9
12.7
0.97
416
3313
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
334
2397
2.05
14.08
6.6
5.9
mmol/l
1.2
1.2
0.10
271
2021
(40768443) Skin Pathology biopsy report
60
208
3.12
13.67
1.2
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
143
763
2.19
13.39
1.3
1.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
291
2032
1.95
12.76
3.0
2.7
ug/l
121.1
98.2
0.69
270
1867
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
282
1952
1.94
12.65
2.1
2.0
pmol/l
106.5
97.9
1.66
124
918
(3019550) Sodium [Moles/volume] in Serum or Plasma
526
4855
7.35
12.23
18.2
14.9
mmol/l
139.7
139.8
0.87
515
4726
(3024561) Albumin [Mass/volume] in Serum or Plasma
285
2026
1.87
11.34
4.1
4.0
g/l
36.2
35.7
0.96
270
1891
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
179
1095
1.96
11.30
1.3
1.3
u/ml
0.9
1.7
0.74
56
280
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
450
3743
2.30
11.21
8.4
7.2
u/l
79.5
77.8
0.26
424
3496
(3001604) Monocytes [#/volume] in Blood
315
2328
1.86
10.91
5.7
5.6
e9/l
0.5
0.6
1.81
282
2008
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
224
1489
1.87
10.89
2.4
2.2
u/l
54.9
57.0
0.40
207
1367
(3023103) Potassium [Moles/volume] in Serum or Plasma
525
4871
6.18
10.88
18.3
15.0
mmol/l
4.0
3.9
1.86
513
4733
(3006315) Basophils [#/volume] in Blood
315
2338
1.85
10.66
5.7
5.6
e9/l
0.0
0.0
0.35
279
2019
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
178
1105
1.92
10.64
2.2
2.1
mg/l
3.2
3.1
0.10
148
942
(3019198) Lymphocytes [#/volume] in Blood
319
2380
1.85
10.58
5.8
5.6
e9/l
1.8
1.9
0.84
287
2094
(3021960) Folate [Moles/volume] in Serum or Plasma
178
1110
1.91
10.47
1.5
1.5
nmol/l
22.9
22.2
0.28
151
938
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
298
2186
1.82
10.36
5.7
5.1
mmol/l
1.2
1.2
0.05
264
1970
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
332
2518
1.84
10.33
6.1
5.7
umol/l
10.2
10.1
0.11
312
2385
(3015377) Calcium [Moles/volume] in Serum or Plasma
247
1713
1.82
10.32
3.1
3.3
mmol/l
2.4
2.4
0.58
217
1495
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
81
381
2.33
10.07
1.3
1.2
iu/ml
221.0
145.3
0.87
36
163
(3037522) Nuclear Ab [Titer] in Serum
122
686
2.01
9.62
1.6
1.3
titre
636.0
592.2
0.10
40
159
(3013115) Eosinophils [#/volume] in Blood
319
2429
1.78
9.39
6.0
5.9
e9/l
0.2
0.2
0.29
290
2133
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
512
4652
3.55
8.42
6.0
4.7
mmol/l
6.0
5.9
0.93
467
4235
(42870588) Differential panel, method unspecified - Blood
220
1544
1.72
8.33
5.9
5.6
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
514
4703
3.61
7.90
5.5
4.6
mmol/l
4.8
4.9
1.10
473
4331
(3009508) Creatinine [Moles/volume] in Urine
204
1422
1.70
7.80
3.1
3.0
mmol/l
6.5
6.6
0.11
171
1192
(3019069) Monocytes/100 leukocytes in Blood
287
2201
1.66
7.53
6.4
6.0
%
8.5
8.4
0.26
271
2039
(3013826) Glucose [Moles/volume] in Serum or Plasma
332
2645
1.68
7.50
4.9
4.1
mmol/l
6.7
6.6
0.46
310
2471
(3019225) pH of Specimen
88
480
2.00
7.44
4.7
3.7
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
498
4503
2.61
7.42
4.8
4.1
mmol/l
1.3
1.3
0.20
453
4094
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
511
4681
3.22
7.41
5.4
4.5
mmol/l
1.5
1.6
1.29
467
4291
(3037467) Urinalysis macro (dipstick) panel - Urine
392
3272
1.75
7.37
5.2
4.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
145
931
1.77
7.37
1.4
1.3
u/ml
24.0
12.2
0.64
50
349
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
492
4429
2.44
7.32
7.1
5.7
mmol/mol
39.9
39.5
0.58
451
4090
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
147
950
1.76
7.29
1.4
1.3
iu/ml
35.3
31.8
0.13
57
317
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
282
2164
1.64
7.29
2.6
2.3
nmol/l
83.3
79.2
1.40
253
1934
(3022096) Basophils/100 leukocytes in Blood
277
2117
1.64
7.27
6.1
5.8
%
0.8
0.7
3.18
259
1949
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
518
4798
3.83
7.05
6.2
5.1
mmol/l
2.8
2.8
0.51
473
4403
(3002030) Lymphocytes/100 leukocytes in Blood
289
2244
1.63
7.03
6.4
5.9
%
29.7
28.7
0.98
272
2072
(3006504) Eosinophils/100 leukocytes in Blood
283
2187
1.63
7.01
6.1
5.7
%
3.1
2.8
1.42
263
2012
(3022948) Iron [Moles/volume] in Serum or Plasma
112
677
1.83
6.92
1.8
2.2
umol/l
14.1
12.8
0.99
98
627
(3031040) Bacteria [#/volume] in Urine by Automated count
379
3158
1.69
6.91
5.4
4.6
—
1069.0
—
0
51
(3019309) Folate [Moles/volume] in Red Blood Cells
133
848
1.76
6.87
1.8
1.7
nmol/l
1343.8
1224.3
0.62
100
617
(3012516) Albumin [Mass/volume] in Urine
193
1370
1.64
6.65
3.2
3.0
mg/l
822.3
250.6
0.49
113
779
(3007853) Bacteria identified in Skin by Aerobe culture
85
476
1.93
6.64
1.7
1.6
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
525
4989
4.48
6.64
13.7
10.6
u/l
26.0
23.8
2.39
511
4798
(3048689) Calprotectin [Mass/mass] in Stool
97
575
1.84
6.35
1.9
2.1
ug/g
188.1
131.9
0.30
71
447
(3013512) EKG study
198
1429
1.61
6.31
3.6
3.6
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
359
2984
1.62
6.26
3.7
2.9
u/l
47.2
45.0
0.15
330
2755
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
148
996
1.67
6.21
1.8
1.7
pmol/l
490.0
30645612.5
1.32
117
806
(3007164) IgA [Mass/volume] in Serum or Plasma
143
954
1.68
6.20
1.4
1.5
g/l
2.4
2.3
0.23
90
544
(3012095) Magnesium [Moles/volume] in Serum or Plasma
113
707
1.76
6.18
2.5
3.0
mmol/l
0.8
0.8
0.17
101
653
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
46
209
2.31
6.18
1.9
2.2
u/l
45.1
39.9
0.90
34
188
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
33
128
2.68
6.16
1.3
1.3
u/ml
96.3
50.7
—
6
16
(3018010) Neutrophils/100 leukocytes in Blood
281
2213
1.57
6.11
6.1
5.6
%
55.3
56.8
1.48
264
2052
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
504
4647
2.55
6.02
16.2
13.2
mg/l
16.2
21.1
4.20
421
3615
(3004789) Transferrin [Mass/volume] in Serum or Plasma
101
622
1.77
5.81
1.7
2.1
g/l
2.4
2.4
0.32
90
580
(3013650) Neutrophils [#/volume] in Blood by Automated count
334
2755
1.57
5.79
9.2
9.0
e9/l
3.6
3.9
2.95
305
2426
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
226
1718
1.55
5.60
3.6
3.5
ng/l
973.0
48.2
0.48
144
1172
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
327
2697
1.55
5.56
2.9
2.8
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
181
1316
1.57
5.43
2.4
2.8
ng/l
690.9
929.2
0.67
146
1112
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
37
162
2.38
5.41
1.4
1.3
u/ml
3.6
3.6
—
8
28
(3020682) Albumin/Creatinine [Ratio] in Urine
195
1445
1.55
5.37
3.9
3.8
mg/mmol
4.4
6.1
0.26
111
823
(3013139) Helicobacter pylori Ag [Presence] in Stool
65
358
1.93
5.32
1.3
1.3
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
193
1430
1.55
5.30
2.4
2.1
u/l
114.6
144.9
1.62
185
1350
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
36
159
2.36
5.17
1.4
1.3
u/ml
5.1
2.1
—
8
17
(3003458) Phosphate [Moles/volume] in Serum or Plasma
90
555
1.75
5.13
3.9
4.1
mmol/l
1.0
1.0
1.27
81
506
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
201
1520
1.52
4.95
3.0
2.8
u/l
30.1
29.1
0.28
189
1451
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
97
620
1.69
4.85
5.6
4.5
%
34.1
33.8
0.08
69
388
(3033658) Prothrombin time (PT) actual/Normal
158
1139
1.55
4.83
3.3
3.4
%
97.4
95.7
0.39
149
1108
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
19
64
3.04
4.60
1.5
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
19
64
3.04
4.60
1.5
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
19
64
3.04
4.60
1.5
1.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
156
1140
1.52
4.43
2.6
2.4
umol/l
320.0
5918.5
4.51
133
971
(3004616) Nuclear Ab [Presence] in Serum
20
72
2.85
4.33
1.3
1.2
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
521
4962
3.22
4.32
19.3
15.7
umol/l
71.3
70.6
0.24
521
4962
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
149
1085
1.52
4.29
1.7
1.5
mg/l
0.9
1.1
0.28
116
844
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
483
4471
1.86
4.26
14.7
12.6
ml/min/173m2
79.1
79.3
0.08
427
3649
(40761511) CBC panel - Blood by Automated count
511
4830
2.40
4.16
16.1
12.7
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
227
1806
1.45
4.16
4.9
7.3
inr
1.1
1.2
2.48
76
535
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
17
57
3.05
4.16
1.6
1.6
%
50.5
57.2
—
10
36
(3045414) Leukocytes [Presence] in Urine
43
224
2.00
4.15
1.6
1.9
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
69
419
1.74
4.14
3.2
3.0
ng/l
86.8
76.6
0.29
52
369
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
146
1067
1.51
4.11
1.3
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
18
63
2.92
4.10
1.6
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
18
63
2.92
4.10
1.6
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
18
64
2.88
3.99
1.6
1.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
281
2337
1.43
3.99
4.0
3.9
estimate
0.0
0.0
0.00
65
449
(40760892) CBC W Ordered Manual Differential panel - Blood
142
1039
1.50
3.96
4.9
4.8
—
—
—
0
0
(3018418) pH of Serum or Plasma
190
1473
1.45
3.95
3.8
3.7
ph
7.4
7.4
0.03
47
282
(46235355) HIV 1 and 2 tests - Meaningful Use set
84
547
1.64
3.89
1.4
1.6
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
130
937
1.51
3.89
2.3
2.7
mmol/l
2.4
2.5
1.24
113
820
(36660697) Celiac disease serology panel - Serum
64
388
1.74
3.87
1.2
1.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
264
2183
1.41
3.81
4.1
3.7
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
109
762
1.54
3.74
1.5
1.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
282
2374
1.40
3.59
5.0
5.2
estimate
0.0
0.0
0.00
65
450
(3009261) Glucose [Presence] in Urine by Test strip
284
2396
1.40
3.56
4.1
3.9
estimate
0.0
0.0
0.80
66
439
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
33
166
2.05
3.52
2.2
1.9
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
53
315
1.76
3.44
2.7
3.1
e9/l
4.2
3.9
0.20
41
240
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
16
59
2.76
3.35
1.3
2.0
mg/l
11.7
28.2
—
5
15
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
88
602
1.55
3.32
7.0
6.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
250
2083
1.38
3.29
9.9
9.3
e9/l
0.0
0.0
0.13
222
1709
(3044889) 12 lead EKG panel
379
3382
1.42
3.28
4.3
3.7
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
86
588
1.55
3.25
1.8
2.2
%
21.7
21.7
0.01
69
502
(3000850) Epithelial cells [#/volume] in Urine
128
951
1.46
3.25
2.2
2.6
e6/l
4.4
7.0
1.59
115
843
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
65
416
1.64
3.23
3.2
3.8
mmol/l
1.2
1.2
0.30
58
356
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
28
138
2.09
3.17
1.3
1.7
iu/l
2.3
4.7
—
10
45
(4010399)
59
372
1.66
3.11
1.4
1.4
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
73
486
1.58
3.10
2.2
2.3
umol/l
6.1
7.1
0.34
63
415
(3026008) Bacteria identified in Urine by Culture
201
1632
1.37
3.04
3.0
3.0
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
35
191
1.89
3.00
1.4
1.6
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
24
115
2.14
2.93
1.5
1.7
e6/l
17070.2
15669.9
0.04
18
81
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
34
186
1.88
2.90
1.4
1.9
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
30
158
1.95
2.86
1.8
1.7
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
158
1247
1.38
2.81
2.7
3.0
e6/l
0.1
0.4
3.81
132
932
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
14
53
2.69
2.81
1.3
1.5
nmol/l
0.2
0.3
—
9
41
(3020961) Endomysium IgA Ab [Titer] in Serum
39
226
1.78
2.79
1.1
1.1
—
167.9
—
0
7
(40758558) Short blood count panel - Blood
157
1241
1.38
2.77
6.7
6.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
161
1278
1.37
2.76
4.7
4.2
estimate
0.0
0.0
0.00
64
445
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
61
403
1.58
2.69
1.9
2.5
ml/min/173m2
68.6
65.8
0.36
33
161
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
51
323
1.64
2.67
1.7
1.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
22
107
2.10
2.61
1.5
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
24
123
2.00
2.49
1.5
2.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
81
580
1.47
2.47
1.3
1.3
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
30
167
1.84
2.46
2.2
1.7
g/l
1.1
1.2
1.02
30
156
(36304419) Bacteria [Presence] in Urine
153
1225
1.35
2.45
2.7
2.9
—
—
—
0
0
(1002224) Polysomnography panel
32
183
1.80
2.41
1.1
1.1
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
5
8
6.30
2.37
1.0
1.1
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
8
22
3.68
2.37
1.9
1.5
pmol/l
13.8
15.0
—
8
16
(40761535) Cells panel - Urine sediment
57
385
1.54
2.30
3.5
3.4
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
15
66
2.31
2.26
1.7
1.4
pmol/l
268.0
325.1
—
9
51
(3018095) Leukocytes [#/volume] in Urine
193
1616
1.30
2.24
3.5
3.7
e6/l
48.5
94.5
1.31
149
1118
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
9
29
3.14
2.23
1.0
1.1
mg/l
288.6
281.9
—
9
24
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
91
680
1.41
2.22
1.9
1.9
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
58
397
1.52
2.21
1.5
1.4
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
26
144
1.85
2.18
2.5
3.0
g/l
0.1
0.2
—
7
45
(3011397) Hemoglobin [Presence] in Urine by Test strip
139
1117
1.33
2.15
3.9
3.8
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
18
88
2.08
2.13
1.5
1.6
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
53
359
1.53
2.13
2.1
2.2
ug/l
7.0
4.4
0.32
44
315
(3000093) Morphology [Interpretation] in Blood Narrative
10
37
2.74
2.11
1.0
1.1
—
—
—
0
0
(4015189)
5
10
5.04
2.07
3.8
3.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
41
264
1.60
2.05
2.5
2.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
26
148
1.80
2.02
1.3
1.3
ug/g
262.7
307.0
0.50
16
81
(3006576) Bicarbonate [Moles/volume] in Blood
5
11
4.58
1.94
6.0
4.5
mmol/l
26.3
24.2
—
5
11
(4094501)
24
135
1.81
1.94
1.0
1.1
—
—
—
0
0
(4024509)
11
45
2.47
1.94
1.5
1.5
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
6
16
3.78
1.94
3.8
2.7
—
—
—
0
0
(4035726)
65
469
1.44
1.93
1.3
1.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
51
351
1.50
1.92
2.3
2.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
22
122
1.84
1.87
1.4
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
40
263
1.56
1.85
1.2
1.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
164
1374
1.28
1.84
1.8
1.6
mmol/l
1.3
1.4
0.73
147
1146
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
6
17
3.56
1.84
2.3
1.2
ug/l
8.4
9.1
—
6
17
(40761536) Microorganisms panel - Urine sediment
57
405
1.46
1.84
4.5
4.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
209
1807
1.26
1.80
4.3
4.0
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
82
625
1.37
1.79
2.3
1.9
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
53
374
1.46
1.78
3.8
4.3
%
0.1
1.0
0.44
15
90
(3022313) Gas panel - Capillary blood
29
178
1.67
1.77
3.8
3.6
—
—
—
0
0
(4062490)
10
41
2.47
1.76
2.0
1.3
—
—
—
0
0
(3024263) Appearance of Synovial fluid
7
24
2.94
1.72
1.1
1.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
10
42
2.41
1.68
2.2
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
10
42
2.41
1.68
2.2
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
10
42
2.41
1.68
2.2
1.6
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
48
336
1.47
1.68
3.9
2.9
e9/l
75.9
74.9
0.06
39
255
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
36
237
1.56
1.67
1.1
1.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
95
749
1.33
1.67
2.4
2.6
e6/l
0.8
1.3
1.66
62
406
(3021788) Differential panel - Synovial fluid
17
90
1.92
1.67
1.4
1.7
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
133
1098
1.28
1.66
4.4
4.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
6
19
3.18
1.66
1.2
2.6
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
160
1352
1.26
1.66
2.8
3.1
e6/l
35.6
51.4
0.28
130
1028
(3009343) pH of Capillary blood
37
246
1.54
1.65
3.9
3.5
ph
7.4
7.4
—
5
42
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
36
238
1.55
1.65
1.2
1.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
11
49
2.27
1.64
2.2
1.5
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
17
91
1.90
1.62
3.3
3.5
e9/l
3.6
4.6
1.26
17
91
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
66
494
1.38
1.62
1.6
1.7
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
12
57
2.13
1.56
1.3
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
37
250
1.52
1.55
2.1
1.7
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
65
490
1.37
1.53
1.4
1.5
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
5
15
3.35
1.52
1.0
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
11
51
2.18
1.51
2.6
3.8
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
35
235
1.52
1.51
3.8
3.4
mmol/l
1.8
2.2
0.26
28
190
(21494755) Public health laboratory ask at order entry panel
21
341
0.60
1.50
1.3
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
61
457
1.38
1.50
2.8
3.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
17
95
1.82
1.44
3.6
3.8
%
55.8
60.2
0.70
17
95
(3034891) Synovial lining cells/100 cells in Synovial fluid
6
22
2.75
1.44
1.7
1.2
—
1.3
—
0
7
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
22
2.75
1.44
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
9
39
2.33
1.43
1.6
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
9
39
2.33
1.43
1.6
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
9
39
2.33
1.43
1.6
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
9
40
2.27
1.40
1.4
1.3
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
9
40
2.27
1.40
1.6
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
9
40
2.27
1.40
1.6
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
9
40
2.27
1.40
1.6
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
12
60
2.02
1.39
1.1
1.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
9
41
2.22
1.37
2.1
1.6
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
23
2.63
1.37
1.8
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
6
23
2.63
1.37
1.8
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
6
23
2.63
1.37
1.8
1.3
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
5
17
2.96
1.36
1.4
1.4
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
55
413
1.37
1.35
1.5
1.7
%
1.4
1.4
0.09
48
361
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
28
184
1.55
1.34
2.3
1.9
mg/l
2.3
5.3
0.52
20
140
(3016018) Differential panel - Cerebral spinal fluid
10
47
2.15
1.34
1.1
1.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
53
398
1.37
1.30
4.3
4.2
%
0.1
0.2
0.08
15
106
(3051593) INR in Capillary blood by Coagulation assay
5
18
2.79
1.28
1.0
14.7
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
10
48
2.10
1.28
2.7
2.5
%
13.9
13.3
—
10
48
(3011288) Drugs identified in Urine by Screen method
9
44
2.06
1.27
1.3
1.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
55
418
1.35
1.26
4.5
4.2
%
1.4
1.1
0.15
16
116
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
8
36
2.24
1.24
1.3
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
6
25
2.42
1.24
3.0
1.7
—
—
—
0
0
(3022621) pH of Urine by Test strip
44
323
1.39
1.24
2.7
2.8
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
9
45
2.02
1.24
2.1
1.6
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
9
45
2.02
1.24
1.1
1.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
129
1098
1.23
1.23
2.6
2.1
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
5
19
2.65
1.22
1.2
1.3
%
94.4
108.3
—
5
19
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
30
206
1.48
1.20
1.9
1.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
18
109
1.67
1.20
3.4
4.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
50
378
1.36
1.19
4.2
4.1
%
1.1
0.7
0.21
12
82
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
6
26
2.32
1.19
4.5
1.5
e6/l
586.7
544.4
—
6
21
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
6
26
2.32
1.19
4.5
1.5
e9/l
0.2
0.2
—
6
21
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
21
134
1.59
1.16
1.5
2.1
ug/l
123.3
179.1
0.82
21
122
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
39
2.07
1.15
1.8
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
20
2.51
1.15
2.0
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
20
2.51
1.15
2.0
1.3
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
20
2.51
1.15
1.2
1.4
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
5
20
2.51
1.15
1.2
1.5
nmol/l
138.2
148.8
—
5
20
(3006462) Nitrate [Presence] in Urine
5
20
2.51
1.15
3.2
3.9
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
164
1441
1.20
1.14
2.5
2.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
8
40
2.01
1.12
1.0
1.1
—
—
—
0
0
(3026782) Osmolality of Urine
104
875
1.23
1.11
2.6
2.7
mosm/kgh2o
451.3
511.2
2.53
89
750
(3000764) Benzodiazepines [Presence] in Urine
14
81
1.75
1.10
1.1
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
14
81
1.75
1.10
1.1
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
14
81
1.75
1.10
1.1
1.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
24
161
1.51
1.08
1.4
1.6
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
7
32
2.20
1.08
1.0
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
13
74
1.78
1.07
1.1
1.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
14
82
1.73
1.06
1.8
1.7
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
65
522
1.28
1.04
9.6
21.2
inr
1.1
1.2
0.57
16
69
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
5
22
2.28
1.03
1.4
1.6
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
22
2.28
1.03
1.2
1.3
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
7
34
2.07
1.03
4.0
6.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
66
533
1.27
1.01
2.9
4.0
ug/l
3.0
8.8
3.04
54
432
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
7
35
2.01
1.00
1.7
1.4
ug/l
13.4
17.9
—
7
35
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
34
250
1.38
0.98
1.4
1.5
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
43
329
1.33
0.98
1.7
2.8
ng/l
124.6
160.5
0.21
38
304
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
7
36
1.96
0.97
1.0
1.2
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
9
50
1.81
0.97
1.1
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
101
861
1.21
0.96
3.2
3.6
ng/l
374.8
175.3
0.37
67
648
(1761482) Bacteria [#/volume] in Urine by Culture
6
117
0.51
0.95
3.5
4.4
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
55
438
1.29
0.95
1.9
2.2
u/l
37.4
35.0
0.11
42
364
(1761868) Lipid panel - Serum or Plasma
182
1637
1.17
0.95
2.6
3.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
6
27
2.24
0.93
1.8
1.8
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
20
134
1.51
0.93
2.1
2.6
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
13
78
1.68
0.92
1.5
1.5
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
11
63
1.76
0.90
1.2
1.8
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
12
71
1.71
0.89
1.2
1.2
nmol/l
—
—
—
0
0
(3000492) Spirometry study
52
417
1.27
0.86
1.4
1.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
118
1032
1.18
0.86
4.2
4.2
kg/l
1.0
1.0
—
10
132
(3002256) Pathology report gross observation
73
610
1.23
0.85
1.5
1.3
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
31
1.95
0.84
2.3
1.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
32
241
1.35
0.82
1.2
1.5
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
58
475
1.25
0.82
7.1
6.4
mmol/l
0.9
1.6
0.99
45
386
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
35
269
1.32
0.80
1.8
1.6
—
—
—
0
0
(4268621)
8
48
1.68
0.79
3.1
2.0
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
9
53
1.71
0.75
1.0
1.1
g/l
1.5
1.5
—
9
47
(3052851) Hemolysis interference index of Serum or Plasma
20
141
1.43
0.75
3.5
3.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
140
1256
1.16
0.75
3.8
3.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
24
2.09
0.74
2.8
1.7
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
24
2.09
0.74
1.0
1.3
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
24
2.09
0.74
2.8
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
24
2.09
0.74
2.8
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
24
2.09
0.74
2.8
1.7
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
5
24
2.09
0.74
5.6
1.6
e9/l
0.1
0.2
—
5
24
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
7
38
1.85
0.73
1.1
1.1
—
0.0
—
0
8
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
22
159
1.40
0.73
1.4
1.6
—
—
—
0
0
(4211845)
5
25
2.01
0.73
3.2
3.3
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
7
39
1.81
0.72
1.3
1.8
nmol/l
62.1
43.7
—
7
39
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
9
57
1.59
0.71
1.1
1.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
5
26
1.93
0.71
1.2
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
26
1.93
0.71
1.8
1.8
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
27
1.86
0.68
1.2
1.7
%
12.6
10.1
—
5
27
(4146454)
7
43
1.64
0.67
4.0
2.7
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
18
128
1.42
0.66
1.7
1.4
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
5
28
1.79
0.66
1.2
2.5
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
7
44
1.60
0.65
1.0
1.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
31
243
1.29
0.64
2.0
3.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
16
112
1.44
0.64
1.8
1.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
37
301
1.25
0.58
1.8
1.7
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
17
123
1.39
0.58
1.1
1.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
79
693
1.16
0.58
2.6
2.8
e6/l
4.0
3.8
0.06
46
350
(3027944) Amphetamines [Presence] in Urine
12
81
1.49
0.57
1.1
1.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
6
36
1.67
0.57
1.0
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
11
73
1.52
0.56
1.2
1.2
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
17
124
1.38
0.56
2.6
1.7
%
88.8
95.4
0.73
17
115
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
8
55
1.46
0.56
1.0
1.0
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
15
107
1.41
0.56
3.2
2.5
u/ml
0.4
0.4
—
8
70
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
15
107
1.41
0.56
1.9
1.7
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
13
90
1.46
0.56
1.0
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
33
267
1.25
0.55
1.6
1.3
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
9
61
1.48
0.54
1.7
1.5
u/l
32.6
36.6
—
9
49
(3008898) HLA-B27 [Presence]
24
187
1.30
0.53
1.1
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
13
91
1.44
0.53
1.5
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
10
66
1.53
0.53
1.6
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
10
67
1.50
0.50
1.0
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
10
67
1.50
0.50
2.1
1.4
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
7
45
1.56
0.49
2.9
2.2
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
7
47
1.50
0.47
1.0
1.0
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
15
111
1.36
0.47
2.9
1.9
%
241.8
186.9
1.00
15
105
(3051611) Lipemic interference index of Serum or Plasma
7
48
1.46
0.47
5.0
2.6
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
19
147
1.30
0.46
1.1
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
19
147
1.30
0.46
1.1
1.1
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
14
186
0.75
0.45
2.6
2.1
%
0.8
0.6
0.58
14
179
(3009542) Hematocrit [Volume Fraction] of Blood
423
4132
1.11
0.45
16.5
14.5
%
39.5
39.1
0.58
273
2878
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
28
230
1.23
0.43
5.7
4.8
%
14.6
21.1
—
10
118
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
32
1.57
0.42
1.6
2.0
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
13
96
1.36
0.42
2.5
2.1
g/l
133.6
127.8
—
8
74
(3050129) First trimester maternal screen panel - Serum or Plasma
8
58
1.38
0.41
1.4
1.4
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
8
58
1.38
0.41
3.8
1.9
pg
31.5
31.6
—
8
58
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
5
33
1.52
0.41
1.2
1.3
—
12.3
—
0
6
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
0
15
0.00
0.41
0.0
2.3
—
6.1
—
0
8
(3002523) Influenza virus A Ag [Presence] in Specimen
8
59
1.36
0.41
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
8
59
1.36
0.41
1.0
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
19
150
1.28
0.40
1.1
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
12
88
1.37
0.40
1.3
1.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
14
106
1.33
0.39
3.4
1.8
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
5
35
1.43
0.39
1.4
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
55
487
1.14
0.38
1.6
1.8
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
11
80
1.38
0.38
1.2
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
9
66
1.37
0.38
1.0
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
5
36
1.39
0.38
1.6
1.7
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
11
81
1.37
0.36
1.6
1.7
—
290.6
—
0
29
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
9
71
1.27
0.36
1.1
1.6
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
9
71
1.27
0.36
1.2
1.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
13
99
1.32
0.35
2.1
2.4
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
32
372
0.85
0.35
2.9
2.9
mmol/l
2.1
2.4
0.21
25
303
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
11
82
1.35
0.34
1.1
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
33
284
1.17
0.34
7.4
5.0
ug/l
1.8
3.4
0.71
27
249
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
54
483
1.13
0.34
1.6
1.8
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
6
45
1.34
0.34
1.2
1.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
6
47
1.28
0.32
2.8
2.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
396
3880
1.08
0.31
19.0
16.6
%
13.6
13.7
0.93
391
3795
(3045142) Bone marrow Pathology biopsy report
7
52
1.35
0.31
1.1
1.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
24
203
1.19
0.30
12.0
7.8
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
7
55
1.28
0.30
1.1
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
10
130
0.76
0.29
1.6
1.8
—
—
—
0
0
(4034850)
11
140
0.78
0.28
13.4
9.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
121
1141
1.08
0.28
1.5
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
8
63
1.27
0.28
1.0
1.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
120
0.75
0.27
1.6
1.1
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
24
206
1.17
0.26
1.2
1.7
—
8.1
—
0
6
(40768793) Breast Pathology biopsy report
23
197
1.18
0.26
1.1
1.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
188
1.18
0.25
2.7
1.8
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
188
1.18
0.25
2.7
1.8
g/l
3.8
3.8
0.01
17
149
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
188
1.18
0.25
2.7
1.8
g/l
7.5
7.6
0.06
17
152
(3021901) Oxygen saturation in Capillary blood
9
77
1.17
0.24
2.6
2.8
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
15
125
1.21
0.22
4.8
2.3
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
3.0
—
9.5
—
0
11
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
0
11
0.00
0.21
0.0
1.1
—
60.7
—
0
6
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.3
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
12
0.00
0.21
0.0
2.0
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
43
1.16
0.21
1.0
1.7
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.9
—
153.8
—
0
13
(44790049)
6
48
1.25
0.20
1.5
1.6
—
—
—
0
0
(44806118)
6
48
1.25
0.20
1.5
1.6
—
—
—
0
0
(44790047)
6
48
1.25
0.20
1.5
1.6
—
—
—
0
0
(44790048)
6
48
1.25
0.20
1.5
1.6
—
—
—
0
0
(4198724)
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
6
50
1.20
0.19
1.0
1.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
6
50
1.20
0.19
3.0
3.0
—
—
—
0
0
(3000991) Gas panel - Venous blood
29
322
0.89
0.19
11.0
6.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
10
122
0.82
0.19
1.7
1.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
7
59
1.19
0.18
2.4
2.7
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5
69
0.72
0.17
1.2
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
8
70
1.15
0.16
1.1
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
17
149
1.15
0.16
1.3
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
10
83
1.21
0.15
6.1
3.1
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
28
255
1.10
0.15
9.9
7.2
%
0.7
0.7
0.09
28
255
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
81
1.11
0.15
1.2
1.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
13
112
1.16
0.14
2.7
1.6
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
28
256
1.10
0.14
9.9
7.2
%
1.3
1.3
0.28
28
256
(3004716) Salmonella sp identified in Stool by Organism specific culture
27
247
1.10
0.14
1.3
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
30
279
1.08
0.11
4.2
4.9
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
12
136
0.88
0.11
2.2
4.4
mmol/l
3.8
3.8
0.00
12
123
(3005033) Fetal Nuchal fold Thickness US
5
46
1.09
0.09
1.4
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
5
46
1.09
0.09
1.4
1.5
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
5
46
1.09
0.09
2.0
1.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
48
1.04
0.09
1.4
1.6
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
11
97
1.14
0.09
1.4
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
6
54
1.11
0.09
1.0
1.7
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
6
54
1.11
0.09
1.0
1.8
%
91.5
90.2
—
6
54
(3020891) Body temperature
15
165
0.91
0.09
3.7
4.7
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
6
57
1.05
0.08
1.5
2.6
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
5
64
0.78
0.08
1.6
1.5
—
—
—
0
0
(4306422)
5
64
0.78
0.08
1.0
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
65
1.08
0.08
1.1
1.5
—
—
—
0
0
(4281824)
8
75
1.07
0.07
1.0
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
8
93
0.86
0.06
1.8
2.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
19
177
1.08
0.06
5.4
3.1
ug/l
0.6
0.8
0.40
13
121
(3030981) Hyaline casts [#/volume] in Urine by Automated count
24
227
1.06
0.06
2.5
2.8
e6/l
0.3
0.2
0.68
24
218
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
23
242
0.95
0.05
1.4
1.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
12
129
0.93
0.03
1.4
1.2
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
16
151
1.06
0.03
1.6
1.7
g/l
0.0
0.0
0.50
16
141
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
35
343
1.02
0.01
1.7
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
36
367
0.98
0.01
1.4
1.7
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
10
94
1.07
0.01
4.5
3.2
nmol/l
0.8
0.9
—
5
76
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
10
94
1.07
0.01
1.2
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
10
94
1.07
0.01
1.2
1.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
12
117
1.03
0.00
1.2
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
25
254
0.98
0.00
1.5
1.6
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
15
147
1.02
0.00
1.6
1.7
g/l
0.0
0.0
0.00
15
138
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
15
149
1.01
0.00
1.6
1.7
g/l
0.0
0.0
0.00
15
139
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
6
62
0.97
0.00
1.3
1.4
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
6
60
1.00
0.00
1.3
1.0
—
—
—
0
0
(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
447.5
—
0
6
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
6.7
—
0
5
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
7.6
—
0
6
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
5
51
0.98
0.00
1.4
1.5
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
6
0.00
0.00
0.0
7.0
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
9
0.00
0.00
0.0
2.7
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
8
88
0.91
0.00
1.3
1.3
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
5
51
0.98
0.00
1.4
1.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
7
71
0.99
0.00
1.4
1.3
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
8
86
0.93
0.00
1.8
1.3
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
4.6
—
0.3
—
0
5
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
9
0.00
0.00
0.0
2.6
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
6
0.00
0.00
0.0
2.8
—
0.8
—
0
6
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
6
61
0.98
0.00
1.3
1.5
—
—
—
0
0
(4133840)
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
5
51
0.98
0.00
1.4
1.5
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
5
54
0.93
0.00
1.4
1.6
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
6
66
0.91
0.00
1.2
1.8
%
76.5
55.5
—
6
66
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
6
67
0.89
0.00
1.0
1.1
%
138.7
123.9
—
6
62
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
6
61
0.98
0.00
1.3
1.1
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(40758358) Immune stain study
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
5
51
0.98
0.00
1.4
1.5
—
—
—
0
0
(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
75.7
—
0
6
(3048929) Epstein Barr virus Ab [Presence] in Serum
9
99
0.91
0.00
1.2
1.2
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
3.2
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: K11_ORAL_LICHEN_HYPOT_THYRO – Oral lichen ruber planus, hypothyreosis or thyroxin

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).